PCN90 Cost Effectiveness Analysis of Bendamustine as First Line Treatment for Chronic Lymphocytic Leukaemia in the Netherlands
Abstract
Authors
S. Vandekerckhove K. Holtzer-Goor D. Van Den Steen Y. van Megen P. Huijgens M. Lamotte C. Uyl- de Groot